Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Monday, December 2, 2013

Nyloxin, an Over-the-Counter (OTC), for MS Pain...

Nutra Pharma Finalizes Exclusive Network Marketing Distribution Agreement for Nyloxin


Nutra Pharma Is Announcing That MyNyloxin Will Have the Exclusive Distribution Rights for the Company's Over-the-Counter (OTC) Pain Reliever, Nyloxin(R) in the Network Marketing Channel

CORAL SPRINGS, FL--(Marketwired - Dec 2, 2013) - Nutra Pharma Corp. (OTCQB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), is announcing that MyNyloxin, a new Network Marketing company, will have the exclusive rights to market and distribute Nutra Pharma's over-the-counter (OTC) pain reliever, Nyloxin®, in the Network Marketing channel. Nutra Pharma will continue to market the products through their retail and Direct Response distributors.

In September 2012, Nutra Pharma announced the beginning of distribution efforts by the TCN group of direct distributors. Since that time, TCN has worked diligently to introduce Nyloxin® to approximately 40,000 distributors in the United States and almost 400,000 distributors globally. TCN has now created a stand-alone opportunity for distributors under the name MyNyloxin. The launch will take place throughout the month of December and will include webinars, internet, radio and television advertising.

"The Nyloxin products continue to represent a wonderful opportunity for our distributors," commented Dalton Johnson, CEO of MyNyloxin. "The new focus of the Company is solely on the Nyloxin opportunity for our Distributors. These are pain-relievers and anti-inflammatory drugs that have provided great results with almost no risk of side effects. With the rollout through the next several months, our goal is to achieve significant sales through our distributors that will provide continuity as they use and order the product every month," he concluded.

Nyloxin® is an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Nyloxin® is currently available in the United States as an oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress. In addition to its everyday strength formulation, Nyloxin® is also offered in an extra strength formula for more advanced, Stage 3, chronic pain. The Company recently announced the beginning of marketing efforts by New Vitality for the Direct Response and retail marketing of Nyloxin. New Vitality's first Nyloxin television commercials are scheduled to begin shortly.


……..

To comment - click the comment link shown below
…….
USE OUR SHARE LINKS at the top of this page  - to provide this article to others
……
REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org  to register
…………………….
.

No comments: